Board of Directors

Promethera® Biosciences is strategically advised by a distinguished international board of directors to drive us towards our goal of being the global leader in innovative cell therapies for liver diseases.

Charles L. Dimmler, III

Chairman of the Board

Tajio Enoki

Director

Reiko Namikawa – MD, PhD

Director

Masaki Doi – PhD

Director

Edward Haack

Director

Etienne Sokal – MD, PhD

Founder & Group CMO

John Tchelingerian – PhD

President & CEO